Research Article

The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy

Table 2

ESI-TOF/MS data for compounds identified in Xiaozeng Qianggu tablets.

No.Retention time (min)Addition modeMolecular formulaMolecular weightError in ppmCompound nameStructuresComposition attribution

11.34[M-H]-C6H6O3125.02400.85-HydroxymethylfurfuralJianqu and Maiya
21.86[M-H]-C15H22O10361.11401.4CatalpolShudihuang
31.88[M-H]-C16H22O11389.1078−1.5MonotropeinLuxiancao
42.43[M-H]-C27H42O20685.2184−1Rehmannioside DShudihuang
52.67[M-H]-C7H6O4153.01901.3Protocatechuic acidGouji and Haitongpi and Jixueten
63.63[M-H]-C16H22O10373.11401.3Geniposidic acidRoucongrong
74.34[M-H]-C7H6O3137.0240.7ProtocatechualdehydeGouji
84.53[M-H]-C15H18O9341.08812.31-O-caffeoyl-β-D-glucopyranoseGusuibu
95.12[M-H]-C16H24O10375.1289−0.58-Epiloganic acidRoucongrong
105.42[M-H]-C20H30O12461.16600.2DecaffeoylacteosideRoucongrong
115.84[M-H]-C16H24O10375.1289−0.5Loganic acidRoucongrong
126.55[M-H]-C16H18O9353.08802Chlorogenic acidRoucongrong and Shanzha and Haitongpi
137.4[M-H]-C16H18O9353.08802Cryptochlorogenic acidRoucongrong & Shanzha and Haitongpi
148.87[M-H]-C21H26O13485.13011.25,7-Dihydroxychromone 7-rutinosideGusuibu
1511.56[M-H]-C27H30O15593.15060.5BiorobinGusuibu
1612.56[M-H]-C35H46O20785.2514−0.1Purpureaside CShudihuang
1713.29[M-H]-C35H46O20785.2514−0.1EchinacosideShudihuang & Roucongrong
1813.67[M-H]-C21H20O12463.0876−0.2HyperosideLuxiancao and Shanzha
1915[M-H]-C27H32O15595.16691NeoeriocitrinGusuibu
2015.29[M-H]-C36H48O20799.2651−1.3Jionoside A1Shudihuang
2116.09[M-H]-C29H36O15623.1961−2.4VerbascosideShudihuang and Roucongrong
2217.12[M-H]-C29H36O15623.1961−2.4IsoacteosideShudihuang & Roucongrong
2317.26[M-H]-C27H32O14579.1709−0.9NaringinGusuibu and Shanzha
2419.65[M-H]-C31H38O16665.209522′-acetylacteoside -Roucongrong
2520.94[M-H]-C15H10O7301.03511QuercetinLuxiancao and Shanzha
2621.12[M-H]-C31H38O16665.20952Tubuloside BRoucongrong
2721.85[M-H]-C31H40O15651.23001.7MartynosideShudihuang